Report Code: CMI58323

Published Date: October 2024

Pages: 320+

Category: Healthcare

Reports Description

The US Pacemaker Manufacturers Market was valued at USD 1,635.7 million in 2024 and is expected to reach USD 2,799.9 million by 2033, at a CAGR of 5.67% during the forecast period 2024 – 2033.

A pacemaker is a small electronic device that prevents the heart from beating too slowly. Patients need to undergo surgery to get a pacemaker, which is placed under the skin near the collarbone. Pacemakers are available in various shapes, such as single-chamber, dual-chamber, and biventricular pacemakers. They are also called cardiac pacing devices.

US Pacemaker Manufacturers Market: Growth Factors

Increasing Patients of Chronic Vascular Diseases in US

The prevalence of various chronic vascular diseases such as abnormal heart rhythms, aorta disease, Marfan syndrome, congenital heart disease, coronary artery disease, heart blockage, and other heart and blood-related diseases are increasing in the United States due to the increasing geriatric population and inclination towards a sedentary lifestyle.

For instance, according to the data published by the US Department of Health and Human Services, about 129 million people in the US have at least 1 major chronic disease. This number is expected to increase during the forecast period owing to the growing prevalence of abnormal cardiac rhythm disorders.

For instance, the same source cited that in the United States, every year, more than 0.85 Mn people suffer from heart attacks. Out of these, about 0.60 Mn are first-time heart attack patients, and 0.20 Mn patients have multiple times heart attacks.

Changing lifestyle and eating habits of people is one of the main reasons of increasing chronic diseases in US. Many chronic diseases are the result of individual health behaviors, such as excessive drinking, smoking, sedentary lifestyles, and poor nutrition; structural socioeconomic and environmental factors play a role in their development, prevention, and management.

Thus, the growing prevalence of chronic diseases is increasing the incidence of chronic pain and the number of surgical procedures, which in turn is driving the demand for Pacemaker Manufacturers.

Growing Geriatric Population in US

Geriatric people are major consumers of pacemakers because they are more susceptible to heart attacks and other cardiovascular diseases. Thus, the growing geriatric population in the US is expected to drive the demand for pacemakers. The geriatric population in the US is increasing rapidly due to longer life expectancy and declining fertility.

People above 65 and older represented 19.2% of the population in 2023. That percentage is expected to grow to 22% by 2040. Nearly 95% of pollution have at least one chronic condition, and nearly 80% have two or more. The leading causes of death among older adults in the US are heart disease, cancer, COVID-19, stroke, chronic lower respiratory diseases,

Every year, millions of prescriptions are written for Pacemaker Manufacturers’ medications. The demand for non-opioid-based drugs is increasing because they have fewer side effects. Many powerful non-opioid Pacemaker Manufacturers, such as aspirin, ibuprofen, acetaminophen, anticonvulsants, and antidepressants, are currently available in the market.

These non-opioids have more favorable side effects and a lower potential for developing an addiction. The consumption of non-opioid based Pacemaker Manufacturers will not only reduce the development of opioid addiction but will also lead to better perioperative outcomes and enhanced patient recovery.

Furthermore, key players operating in the market are heavily investing in developing customized and error-free pacemakers, which can relieve cardiac pain over a longer period.

US Pacemaker Manufacturers Market: Restraints

High Cost of Pacemakers

The cost of pacemakers is very high due to various factors such as increasing hospital charges, growing inflation, increasing surgery costs, high fees for cardiac surgeries, and complex surgery processes. Pacemaker installation requires highly monitored and specialized operation theatres and surgery centers, which require advanced equipment, well-trained medical staff, and accommodation.

The cost of these services is increasing in the US due to the growing number of patients and inflation. Thus, these factors are increasing the overall installation cost of pacemakers, thereby reducing the profit margin, which in turn discourages investment in the market and reduces the overall market growth.

The absence of skilled surgeons across the US is also restraining the overall market growth during the forecast period. Lack of uniformity in the regulations about pacemaker installations is also expected to restrain the market growth.

Every state has its own set of rules and regulations regarding the usage and implementation of pacemakers. Stakeholders operating in the market find it very difficult to comply with such state-wide regulations, discouraging investment in the market and reducing overall market growth.

The growing use of implantable cardioverter defibrillator (ICD) and gene therapy as a substitute for pacemakers is expected to restrain the market growth. Gene therapy is emerging as the best alternative for pacemakers as it has few side effects and avoids infections. Furthermore, external factors such as patient expirations, genetic competition, availability of alternative therapies & nonpharmacological treatments, high development costs, and lengthy approval processes are restraining the market growth.

US Pacemaker Manufacturers Market: Opportunities

Technological Advancements in the Pacemakers 

Due to a supportive policy framework and increasing investment in cardiac research, the US pacemaker industry is seeing many technological innovations and research and development activities. Various technological innovations, such as remote monitoring, battery efficiency and device design, leadless pacemakers, MRI compatibility, and biocompatibility, are expected to create lucrative opportunities for market growth during the forecast period.

One significant innovation in the pacemaker industry is the innovation of leadless pacemakers. The many key players operating in the market are heavily investing in the development of leadless pacemakers because these pacemakers eliminate the risks by incorporating the pulse generator and electrodes into a single, small device. Leadless pacemakers offer excellent performance, safety features, and a lower risk of lead-associated infection and complications.

Additionally, key players operating in the market are heavily investing in R&D to discover and develop advanced pacemakers. For instance, many key players invest heavily in developing dual and multichamber pacemakers.

These multi-chamber pacemakers can synchronize atrial and ventricular contractions. Dual—and multi-chamber pacemakers use sensors and algorithms to detect the heart’s electrical activity and deliver coordinated impulses. Thus, such technological innovations are expected to create lucrative market opportunities during the forecast period.

US Pacemaker Manufacturers Market: Segmentation Analysis

Segmenting the US Pacemaker Manufacturers Market by product, technology, type, application, end user, and region. By Product, the market is further segmented into implantable and external pacemakers.

Among all these, implantable pacemakers dominated the global market in 2023 and are expected to keep their dominance during the forecast period owing to the growing implantation of pacemakers across the US. Implantable pacemakers are available in various shapes and forms, such as single chambers, multi-chambers, and dual chambers.

The implantation of pacemakers among patients is increasing worldwide due to the increasing number of cardiovascular surgeries. The pacemaker is implanted in the chest to regulate and maintain the electrical flow to the heart.

The external pacemakers segment is expected to grow at the fastest CAGR during the forecast period owing to the growing usage of external pacemakers to regulate the myocardiocyte and effectively regulate and maintain heart rates and cardiac output. External pacemakers, or transcutaneous pacemakers, temporarily stabilise the patient’s heart condition and blood pressure.

By technology, the dual chamber segment dominated the market in 2023 and is expected to continue doing so during the forecast period. Dual chamber pacemakers are very small, battery-powered devices used to maintain heart rhythm and blood flow to the heart.

The dual chamber has two leads connecting to both chambers on the right side of the heart, the right atrium, and the right ventricle. Key players have innovated new dual-chamber pacemakers incorporating various programmable features. These features allow the dual pacemaker to adjust the AV interval automatically in response to paced versus sensed P waves.

The multichamber segment is expected to grow at the fastest CAGR during the forecast period. Multichamber pacemakers contain multiple chambers and multiple wires. Due to their advanced and multidimensional features, these pacemakers are widely used across the US.

By Type, the conventional pacemaker segment dominated the market in 2023. It is expected to keep its dominance during the forecast period because it is very easy to handle and less complex. Various benefits of conventional pacemakers, such as their ease of handling, lower cost, small size, and elongated shelf life, are mainly boosting the market growth of this segment.

The MRI-compatible pacemaker segment is expected to grow at the fastest CAGR during the forecast period owing to their growing popularity across the US. Furthermore, increasing advances in MRI technology coupled with growing investment in pacemaker research and development are some of the factors expected to create lucrative opportunities for market growth during the forecast period.

The hospital segment held the highest market share by end user in 2023. Owing to the growing number of hospitals in the US, it is expected to keep its dominance during the forecast period 2024-2033. Furthermore, various other factors, such as the presence of well-equipped hospitals, supportive government initiatives across the U.S., and increasing credibility of hospitals due to the presence of expert surgeons in the US, are expected to propel the market growth of this segment during the forecast period.

Government and private companies’ growing emphasis on developing multispecialty hospitals is expected to create lucrative opportunities for this segment during the forecast period.

Cardiac Surgery Centers held the second-largest market share in 2023 and are expected to grow significantly during the forecast period. Patients’ increasing preference for cardiac surgeries in cardiac surgery centers due to short waiting times and the easy availability of specialists are some of the factors driving the market growth of this segment during the forecast period.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 1,635.7 Million
Projected Market Size in 2033 USD 2,799.9 Million
Market Size in 2023 USD 1,550 Million
CAGR Growth Rate 5.67% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product, Technology, Type, Application, End User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Country Scope US
Buying Options Request tailored purchasing options to fulfil your research requirements.

List of the prominent players in the US Pacemaker Manufacturers Market:

  • OSYPKA MEDICAL
  • Boston Scientific Corporation
  • Asahi Kasei Group Company
  • Medtronic
  • BIOTRONIK SE & Co. KG
  • MicroPort Scientific Corporation
  • MEDICO S.R.L.
  • Shree Pacetronix Ltd.
  • Abbott
  • OSCOR Inc
  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • MEDICO
  • Others

The US Pacemaker Manufacturers Market is segmented as follows:

By Product

  • Implantable pacemakers
  • External pacemakers

By Technology

  • Single Chamber
  • Dual Chamber
  • Biventricular Chamber

By Type

  • MRI Compatible Pacemakers
  • Conventional Pacemakers

By Application

  • Arrhythmias
  • Atrial Fibrillation
  • Heart Block
  • Long QT Syndrome
  • Congestive Heart Failure
  • Others

By End User

  • Hospitals
  • Cardiac Surgery Centers
  • Ambulatory Surgical Centers
  • Others

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 US Pacemaker Manufacturers Market (2024 – 2033) (USD Million)
    • 2.2 US Pacemaker Manufacturers Market: snapshot
  • Chapter 3. US Pacemaker Manufacturers Market: Industry Analysis
    • 3.1 US Pacemaker Manufacturers Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing Patients of Chronic Vascular Diseases in the US
      • 3.2.2 Growing Geriatric Population in the US
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Product
      • 3.7.2 Market Attractiveness Analysis By Technology
      • 3.7.3 Market Attractiveness Analysis By Type
      • 3.7.4 Market Attractiveness Analysis By Application
      • 3.7.5 Market Attractiveness Analysis By End User
  • Chapter 4. US Pacemaker Manufacturers Market: Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 US Pacemaker Manufacturers Market: company market share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. US Pacemaker Manufacturers Market: Product Analysis
    • 5.1 US Pacemaker Manufacturers Market Overview: By Product
      • 5.1.1 US Pacemaker Manufacturers Market Share, By Product, 2023 and 2033
    • 5.2 Implantable pacemakers
      • 5.2.1 US Pacemaker Manufacturers Market by Implantable Pacemakers, 2024 – 2033 (USD Million)
    • 5.3 External pacemakers
      • 5.3.1 US Pacemaker Manufacturers Market by External Pacemakers, 2024 – 2033 (USD Million)
  • Chapter 6. US Pacemaker Manufacturers Market – Technology Analysis
    • 6.1 US Pacemaker Manufacturers Market Overview: By Technology
      • 6.1.1 US Pacemaker Manufacturers Market Share, By Technology, 2023 and 2033
    • 6.2 Single Chamber
      • 6.2.1 US Pacemaker Manufacturers Market by Single Chamber, 2024 – 2033 (USD Million)
    • 6.3 Dual Chamber
      • 6.3.1 US Pacemaker Manufacturers Market by Dual Chamber, 2024 – 2033 (USD Million)
    • 6.4 Biventricular Chamber
      • 6.4.1 US Pacemaker Manufacturers Market by Biventricular Chamber, 2024 – 2033 (USD Million)
  • Chapter 7. US Pacemaker Manufacturers Market – Type Analysis
    • 7.1 US Pacemaker Manufacturers Market Overview: By Type
      • 7.1.1 US Pacemaker Manufacturers Market Share, By Type, 2023 and 2033
    • 7.2 MRI Compatible Pacemakers
      • 7.2.1 US Pacemaker Manufacturers Market by MRI Compatible Pacemakers, 2024 – 2033 (USD Million)
    • 7.3 Conventional Pacemakers
      • 7.3.1 US Pacemaker Manufacturers Market by Conventional Pacemakers, 2024 – 2033 (USD Million)
  • Chapter 8. US Pacemaker Manufacturers Market – Application Analysis
    • 8.1 US Pacemaker Manufacturers Market Overview: By Application
      • 8.1.1 US Pacemaker Manufacturers Market Share, By Application, 2023 and 2033
    • 8.2 Arrhythmias
      • 8.2.1 US Pacemaker Manufacturers Market by Arrhythmias, 2024 – 2033 (USD Million)
    • 8.3 Atrial Fibrillation
      • 8.3.1 US Pacemaker Manufacturers Market by Atrial Fibrillation, 2024 – 2033 (USD Million)
    • 8.4 Heart Block
      • 8.4.1 US Pacemaker Manufacturers Market by Heart Block, 2024 – 2033 (USD Million)
    • 8.5 Long QT Syndrome
      • 8.5.1 US Pacemaker Manufacturers Market by Long QT Syndrome, 2024 – 2033 (USD Million)
    • 8.6 Congestive Heart Failure
      • 8.6.1 US Pacemaker Manufacturers Market by Congestive Heart Failure, 2024 – 2033 (USD Million)
    • 8.7 Others
      • 8.7.1 US Pacemaker Manufacturers Market by Others, 2024 – 2033 (USD Million)
  • Chapter 9. US Pacemaker Manufacturers Market: End User Analysis
    • 9.1 US Pacemaker Manufacturers Market Overview: By End User
      • 9.1.1 US Pacemaker Manufacturers Market Share, By End User, 2023 and 2033
    • 9.2 Hospitals
      • 9.2.1 US Pacemaker Manufacturers Market by Hospitals, 2024 – 2033 (USD Million)
    • 9.3 Cardiac Surgery Centers
      • 9.3.1 US Pacemaker Manufacturers Market by Cardiac Surgery Centers, 2024 – 2033 (USD Million)
    • 9.4 Ambulatory Surgical Centers
      • 9.4.1 US Pacemaker Manufacturers Market by Ambulatory Surgical Centers, 2024 – 2033 (USD Million)
    • 9.5 Others
      • 9.5.1 US Pacemaker Manufacturers Market by Others, 2024 – 2033 (USD Million)
  • Chapter 10. US Pacemaker Manufacturers Market: Regional Analysis
    • 10.1 US Pacemaker Manufacturers Market Regional Overview
    • 10.2 US Pacemaker Manufacturers Market Share, by Region, 2023 & 2033 (USD Million)
  • Chapter 11. Company Profiles
    • 11.1 OSYPKA MEDICAL
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 Boston Scientific Corporation
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 Asahi Kasei Group Company
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Medtronic
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 BIOTRONIK SE & Co. KG
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 MicroPort Scientific Corporation
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 MEDICO S.R.L.
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 Shree Pacetronix Ltd.
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Abbott
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 OSCOR Inc
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 Zoll Medical Corporation
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 MicroPort Scientific Corporation
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 MEDICO
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 Others.
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
List Of Figures

Figures No 1 to 32

List Of Tables

Tables No 1 to 2

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2033

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2033
  • Market revenue estimates and forecasts up to 2033, by technology
  • Market revenue estimates and forecasts up to 2033, by application
  • Market revenue estimates and forecasts up to 2033, by type
  • Market revenue estimates and forecasts up to 2033, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • OSYPKA MEDICAL
  • Boston Scientific Corporation
  • Asahi Kasei Group Company
  • Medtronic
  • BIOTRONIK SE & Co. KG
  • MicroPort Scientific Corporation
  • MEDICO S.R.L.
  • Shree Pacetronix Ltd.
  • Abbott
  • OSCOR Inc
  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • MEDICO
  • Others

FAQs

The major drivers for the US Pacemaker Manufacturers Market are growing geriatric population, increasing prevalence of chronic diseases.

The “Arrhythmias” had the largest share in the market for US Pacemaker Manufacturers.

The “MRI Compatible Pacemakers” category dominated the market in 2023.

The key players in the market are OSYPKA MEDICAL, Boston Scientific Corporation, Asahi Kasei Group Company, Medtronic, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, MEDICO S.R.L., Shree Pacetronix Ltd., Abbott, OSCOR Inc, Zoll Medical Corporation, MicroPort Scientific Corporation, MEDICO, Others.

The market is projected to grow at a CAGR of 5.67% during the forecast period, 2024-2033.

The US Pacemaker Manufacturers Market size was valued at USD 1,635.7 Million in 2024.

PURCHASE OPTIONS

$

3990


$

4990


$

5990


$

2290


$

2390

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?
100% FREE CUSTOMIZATION!